Chimeron Bio receives NIH (NCI) Innovative Concept Award for mRNA cancer vaccine development
read more
https://www.chimeron.com/wp-content/uploads/2024/06/RECIPIENT-Innovative-Concept-Award.png
900
900
Chimeron Bio | Pioneering In-Vivo CAR-T Therapy
Chimeron Bio | Pioneering In-Vivo CAR-T Therapy
https://www.chimeron.com/wp-content/uploads/2024/06/RECIPIENT-Innovative-Concept-Award.png
Pioneering MultiPlex In-Vivo CAR-T Therapy
A new wave in genetic medicine - multiplexed, precise, and delivered at scale.
Breakthrough Science
MultiPlex genetic engineering previously thought impossible in vivo
Creating transformative impact through complex, multi-gene therapeutic constructs delivered directly in vivo for precision at scale.
Redefining What's Possible in Cell Therapy
"We envision a world where the most advanced cell therapies are as accessible as traditional biologics – delivered directly in the patient with the precision of genetic medicine and the potency of engineered immunity." - Kevin Heyeck, CEO
Three Pillars to our approach
Breakthrough Science
MultiPlex genetic engineering previously thought impossible in vivo
Transformative Impact
From complex manufacturing to simple injection – revolutionizing patient access
Limitless Potential
Therapeutic applications spanning oncology, autoimmunity, and beyond
In the News
The Latest from Chimeron Bio
Chimeron Bio recognized by MilliporeSigma as a finalist in the Advance Biotech Grant Award
read more
https://www.chimeron.com/wp-content/uploads/2024/06/Chimeron-Finalist-Award-Advance-Biotech-Grant-Award-June-2023.png
750
750
Chimeron Bio | Pioneering In-Vivo CAR-T Therapy
Chimeron Bio | Pioneering In-Vivo CAR-T Therapy
https://www.chimeron.com/wp-content/uploads/2024/06/Chimeron-Finalist-Award-Advance-Biotech-Grant-Award-June-2023.png
Chimeron Bio recognized by MilliporeSigma as a finalist in the Advance Biotech Grant Award
Chimeron Bio Appoints Antonin de Fougerolles to its Board of Directors
read more
https://www.chimeron.com/wp-content/uploads/2023/05/Tony-de-Fougerolles-PhD.png
300
300
Chimeron Bio | Pioneering In-Vivo CAR-T Therapy
Chimeron Bio | Pioneering In-Vivo CAR-T Therapy
https://www.chimeron.com/wp-content/uploads/2023/05/Tony-de-Fougerolles-PhD.png
Chimeron Bio Appoints Antonin de Fougerolles to its Board of Directors
Chimeron Bio Welcomes Kevin Heyeck as New CEO
read more
https://www.chimeron.com/wp-content/uploads/2023/05/MicrosoftTeams-image-78-1.png
300
300
Chimeron Bio | Pioneering In-Vivo CAR-T Therapy
Chimeron Bio | Pioneering In-Vivo CAR-T Therapy
https://www.chimeron.com/wp-content/uploads/2023/05/MicrosoftTeams-image-78-1.png
Chimeron Bio Welcomes Kevin Heyeck as New CEO
Chimeron Bio Enters Into Manufacturing Agreement With FUJIFILM Diosynth Biotechnologies to Advance its RNA Oncology Candidates
read more
https://www.chimeron.com/wp-content/uploads/2023/05/FUJI.webp
206
206
Chimeron Bio | Pioneering In-Vivo CAR-T Therapy
Chimeron Bio | Pioneering In-Vivo CAR-T Therapy
https://www.chimeron.com/wp-content/uploads/2023/05/FUJI.webp